Pe baza de reteta
Fraxiparine 3800 ui anti-factor xa/0,4 ml, solutie injectabila, 10 seringi preumplute, Aspen Pharma Trading
Link documentare prospect: https://www.anm.ro/_/_PRO/pro_2520_10.05.10.pdf
ASPEN PHARMA TRADINGLocoid lipocream 1 mg/g, crema, Leo Pharma A/S
Link documentare prospect: https://www.anm.ro/_/_PRO/PRO_8684_23.02.16.pdf
LEO PHARMA A/SLocoid 1 mg/g, crema, Leo Pharma A/S
Link documentare prospect: https://www.anm.ro/_/_PRO/PRO_10914_13.08.18.pdf
LEO PHARMA A/SFraxiparine 7600 ui anti-factor xa/0,8 ml,solutie injectabila, Aspen Pharma Trading
Link documentare prospect: https://www.anm.ro/_/_PRO/pro_2520_10.05.10.pdf
ASPEN PHARMA TRADINGLipofib 160 mg, 30 capsule, Terapia
Link documentare prospect: https://www.anm.ro/_/_PRO/pro_13069_20.03.20.pdf
TERAPIA SAFromilid 250, 14 comprimate filmate, Krka
Link documentare prospect: https://www.anm.ro/_/_PRO/PRO_9032_06.06.16.pdf
KRKA D.D. NOVO MESTOFromilid 500, 14 comprimate filmate, Krka
Link documentare prospect: https://www.anm.ro/_/_PRO/PRO_9033_06.06.16.pdf
KRKA D.D. NOVO MESTOLipantil nano 145 mg, 30 comprimate filmate, Mylan Medical
Indicatii: Lipantil Nano apartine unui grup de medicamente cunoscute in mod obisnuit sub numele de fibrati. Aceste medicamente sunt utilizate pentru a scadea valorile grasimilor (lipidelor) in...
MYLAN MEDICAL SASLipanthyl supra 160 mg, 30 comprimate, Mylan Medical
Link documentare prospect: https://www.anm.ro/_/_PRO/pro_1075_15.10.08.pdf
MYLAN MEDICAL SASGentamicin 80mg/2ml, 10 fiole, solutie injectabila, Krka
Link documentare prospect: https://www.anm.ro/_/_PRO/pro_13061_20.03.20.pdf
KRKA D.D. NOVO MESTOGlucobay 50, 120 comprimate, Bayer AG
Link documentare prospect: https://www.anm.ro/_/_PRO/PRO_8672_23.02.16.pdf
BAYER AGGlucophage 1000 mg, 60 comprimate filmate, Merck sante
Link documentare prospect: https://www.anm.ro/_/_PRO/PRO_7538_08.04.15.pdf
MERCK SANTEIrbesartan teva 150 mg, 28 comprimate filmate, Teva B.V
Link documentare prospect: https://www.ema.europa.eu/en/documents/overview/irbesartan-teva-epar-summary-public_ro.pdf
TEVA B.V.